Two Sigma Investments LP Acquires New Position in LifePoint Health Inc (LPNT)

Two Sigma Investments LP bought a new stake in shares of LifePoint Health Inc (NASDAQ:LPNT) during the fourth quarter, Holdings Channel reports. The fund bought 16,013 shares of the company’s stock, valued at approximately $910,000.

Several other institutional investors have also recently bought and sold shares of the stock. Victory Capital Management Inc. boosted its position in LifePoint Health by 65.2% in the third quarter. Victory Capital Management Inc. now owns 1,692 shares of the company’s stock valued at $100,000 after buying an additional 668 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in LifePoint Health by 1,006.8% in the third quarter. Tower Research Capital LLC TRC now owns 2,756 shares of the company’s stock valued at $163,000 after buying an additional 2,507 shares in the last quarter. ETRADE Capital Management LLC purchased a new position in LifePoint Health during the third quarter valued at about $257,000. Eqis Capital Management Inc. purchased a new position in LifePoint Health during the third quarter valued at about $299,000. Finally, First Citizens Bank & Trust Co. boosted its position in LifePoint Health by 1.7% in the third quarter. First Citizens Bank & Trust Co. now owns 5,233 shares of the company’s stock valued at $310,000 after buying an additional 88 shares in the last quarter. Hedge funds and other institutional investors own 99.88% of the company’s stock.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Shares of LifePoint Health Inc (NASDAQ:LPNT) opened at 62.05 on Monday. The company has a 50-day moving average of $62.74 and a 200 day moving average of $59.41. LifePoint Health Inc has a one year low of $50.60 and a one year high of $75.70. The stock has a market cap of $2.48 billion, a price-to-earnings ratio of 22.00 and a beta of 0.87.

LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, February 17th. The company reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.02. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.63 billion. LifePoint Health had a net margin of 1.93% and a return on equity of 7.02%. The company’s revenue for the quarter was up 17.1% compared to the same quarter last year. During the same period last year, the firm posted $1.11 earnings per share. On average, equities analysts forecast that LifePoint Health Inc will post $4.18 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Two Sigma Investments LP Acquires New Position in LifePoint Health Inc (LPNT)” was originally reported by Mideast Time and is owned by of Mideast Time. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.mideasttime.com/two-sigma-investments-lp-acquires-new-position-in-lifepoint-health-inc-lpnt/1588970.html.

Several research firms recently issued reports on LPNT. Cantor Fitzgerald reiterated a “neutral” rating on shares of LifePoint Health in a research note on Tuesday, February 21st. Piper Jaffray Companies began coverage on shares of LifePoint Health in a research note on Wednesday, January 4th. They issued a “neutral” rating and a $62.00 target price for the company. TheStreet upgraded shares of LifePoint Health from a “c+” rating to a “b-” rating in a research note on Monday, March 13th. Zacks Investment Research upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a research note on Wednesday, February 22nd. Finally, Mizuho boosted their target price on shares of LifePoint Health from $50.00 to $57.00 and gave the company a “neutral” rating in a research note on Tuesday, February 21st. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. LifePoint Health has an average rating of “Hold” and an average target price of $65.30.

In other news, insider David M. Dill sold 18,800 shares of the firm’s stock in a transaction that occurred on Thursday, March 16th. The shares were sold at an average price of $62.22, for a total transaction of $1,169,736.00. Following the transaction, the insider now directly owns 207,873 shares in the company, valued at $12,933,858.06. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP John P. Bumpus sold 26,362 shares of the firm’s stock in a transaction that occurred on Thursday, March 9th. The stock was sold at an average price of $65.05, for a total transaction of $1,714,848.10. Following the transaction, the executive vice president now owns 117,458 shares in the company, valued at $7,640,642.90. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 46,667 shares of company stock worth $2,982,409. Insiders own 7.28% of the company’s stock.

About LifePoint Health

LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.

5 Day Chart for NASDAQ:LPNT

Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health Inc (NASDAQ:LPNT).

Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.